Newsroom

Learn more about us in our featured news stories and insights into our work

News Press Releases Locus Insights

September 10, 2024

Crispr-Enhanced Viruses Are Being Deployed Against UTIs

Learn More
August 12, 2024

Locus Biosciences Announces Positive Results from Part 1 of ELIMINATE Phase 2 Trial of the Engineered Bacteriophage Therapy LBP-EC01 Published in The Lancet Infectious Diseases

Learn More
October 3, 2024

Inside LOCUS AI – How the team uses artificial intelligence

Learn More
September 9, 2024

Phage Therapy’s Neglected Potential Is Finally Being Realized

Learn More
February 1, 2024

Antimicrobial Resistance: Multiple Threats, Multiple Responses

Learn More
February 1, 2024

Locus milestone unlocks more BARDA cash

Learn More
January 26, 2024

Locus Biosciences receives $23.9 million from BARDA for CRISPR-engineered therapy trial

Learn More
January 26, 2024

BARDA backs Locus phage therapy for resistant E coli

Learn More
January 26, 2024

Locus Biosciences Receives $23.9 Million Boost for Bacteriophage Therapy Advancement in UTI Treatment

Learn More
January 26, 2024

BARDA Funds Next Stage of CRISPR-Based Bacteriophage Therapy

Learn More